{
  "trial_id": "NCT02145611",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "years, history of type 2 diabetes and mild hypertension (blood pressure < 160 X 100 mmHg) no longer than 15 years, body mass index < 35 Kg/m2, and glycated hemoglobin older than 35 years;",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "history of type 2 diabetes mellitus and mild hypertension (blood pressure <160 x 100 mmHg) for a shorter period of time as 15 years;",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "body mass index < 35 Kg/m2;",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "plasma concentration of glycated hemoglobin between 7.0 and 10.5%",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "pregnancy or breastfeeding;",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "creatinine clearance < 45 ml/min/m2 (MDRD);",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "use of NPH (neutral protamine Hagedorn) or/and regular insulin;",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "pioglitazone, GLP-1 receptor agonist, DPP-4 inhibitor or acarbose;",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "a serum alanine aminotransferase or aspartate aminotransferase level of more than 3 times the upper limit of the normal range;",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has type 1 diabetes confirmed with molecular analysis 7 years ago. He presents to the clinic with shortness of breath and fatigue during activities.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT02145611",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}